These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36992626)

  • 1. Thermal ablation of ultrasound and non-contrast computed tomography invisible primary and secondary liver tumors: targeting by selective intra-arterial lipiodol injection.
    Kobe A; Tselikas L; Deschamps F; Roux C; Delpla A; Varin E; Hakime A; de Baère T
    Diagn Interv Radiol; 2023 Jul; 29(4):609-613. PubMed ID: 36992626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images.
    Takaki H; Yamakado K; Nakatsuka A; Yamada T; Uraki J; Kashima M; Yamanaka T; Shiraki K; Takei Y; Takeda K
    Int J Clin Oncol; 2013 Feb; 18(1):46-53. PubMed ID: 22016114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transarterial iodized oil injection and computed tomography-guided thermal ablation for hepatocellular carcinoma: utility of the iodized oil retention pattern.
    Tan J; Mathy RM; Chang DH; Tang T; Zhang ZS; Xiao YD
    Abdom Radiol (NY); 2022 Jan; 47(1):431-442. PubMed ID: 34642785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma.
    Wu CH; Liang PC; Su TH; Lin MC; Chang YH; Shih TT; Kao JH
    Hepatol Int; 2021 Oct; 15(5):1247-1257. PubMed ID: 34338971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation for viable hepatocellular carcinoma around retained iodized oil after transcatheter arterial chemoembolization: usefulness of biplane fluoroscopy plus ultrasound guidance.
    Min JH; Lee MW; Rhim H; Choi D; Kim YS; Kim YJ; Cha DI; Lim HK
    Korean J Radiol; 2012; 13(6):784-94. PubMed ID: 23118578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomographic-guided radiofrequency ablation of recurrent or residual hepatocellular carcinomas around retained iodized oil after transarterial chemoembolization.
    Koh YH; Choi JI; Kim HB; Kim MJ
    Korean J Radiol; 2013; 14(5):733-42. PubMed ID: 24043966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography-guided percutaneous microwave ablation with artificial ascites for problematic hepatocellular tumors.
    Wang Y; Zhang L; Li Y; Wang W
    Int J Hyperthermia; 2020; 37(1):256-262. PubMed ID: 32157926
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance.
    Kim JE; Kim YS; Rhim H; Lim HK; Lee MW; Choi D; Shin SW; Cho SK
    Eur J Radiol; 2011 Aug; 79(2):e80-4. PubMed ID: 21514757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma.
    Shinto AS; Karuppusamy KK; Kurup RER; Pandiyan A; Jayaraj AV
    Nucl Med Commun; 2021 Jan; 42(1):43-50. PubMed ID: 32956248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of CT-guided percutaneous thermal ablation for hepatocellular carcinoma adjacent to the second porta hepatis.
    Xie L; Cao F; Qi H; Song Z; Shen L; Chen S; Hu Y; Chen C; Fan W
    Int J Hyperthermia; 2019; 36(1):1122-1128. PubMed ID: 31739695
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.
    Min JH; Lee MW; Cha DI; Jeon YH; Shin SW; Cho SK; Rhim H; Lim HK
    Korean J Radiol; 2013; 14(2):248-58. PubMed ID: 23483753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical report: Lipiodol-guided computed tomography for radiofrequency ablation of hepatocellular carcinoma.
    Gandhi S; Iannitti DA; Mayo-Smith WW; Dupuy DE
    Clin Radiol; 2006 Oct; 61(10):888-91. PubMed ID: 16978986
    [No Abstract]   [Full Text] [Related]  

  • 13. Real-Time US-CT fusion imaging for guidance of thermal ablation in of renal tumors invisible or poorly visible with US: results in 97 cases.
    Mauri G; Monfardini L; Della Vigna P; Montano F; Bonomo G; Buccimazza G; Camisassi N; Rossi D; Maiettini D; Varano GM; Solbiati L; Orsi F
    Int J Hyperthermia; 2021; 38(1):771-776. PubMed ID: 33971779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraprocedural assessment of ablation margins using computed tomography co-registration in hepatocellular carcinoma treatment with percutaneous ablation: IAMCOMPLETE study.
    Hendriks P; van Dijk KM; Boekestijn B; Broersen A; van Duijn-de Vreugd JJ; Coenraad MJ; Tushuizen ME; van Erkel AR; van der Meer RW; van Rijswijk CS; Dijkstra J; de Geus-Oei LF; Burgmans MC
    Diagn Interv Imaging; 2024 Feb; 105(2):57-64. PubMed ID: 37517969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.
    Lintia-Gaultier A; Perret C; Ansquer C; Eugène T; Kraeber-Bodéré F; Frampas E
    Nucl Med Commun; 2013 Jul; 34(7):674-81. PubMed ID: 23587835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).
    Iezzi R; Cesario V; Siciliani L; Campanale M; De Gaetano AM; Siciliano M; Agnes S; Giuliante F; Grieco A; Pompili M; Rapaccini GL; Gasbarrini A; Bonomo L;
    Radiol Med; 2013 Jun; 118(4):555-69. PubMed ID: 23358819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation.
    Lee MW; Kim YJ; Park SW; Hwang JH; Jung SI; Jeon HJ; Kwon WK
    Br J Radiol; 2009 Nov; 82(983):908-15. PubMed ID: 19433482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
    Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Joo I; Morrow KW; Raman SS; McWilliams JP; Sayre JW; Lu DS
    Eur Radiol; 2022 Sep; 32(9):6327-6335. PubMed ID: 35389047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.